°µÍø³Ô¹Ï
Main navigation
°µÍø³Ô¹Ï
°µÍø³Ô¹Ï
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Read more
about ProtagonistTherapeuticsInc-2021-06-15
$132.0 Million
Image
Protagonist Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about PraxisPrecisionMedicines-2021-05-13
$104.9 Million
Image
Praxis Precision Medicines
Follow-On Offering
Active Bookrunner
Read more
about AclarisTherapeuticsInc-2021-06-09
$143.8 Million
Image
Aclaris Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
Read more
about HeskaCorporation-2021-03-02
$175.0 Million
Image
Heska Corporation
Follow-On Offering
Active Bookrunner
Read more
about SolidBiosciencesInc-2021-03-18
$143.7 Million
Image
Solid Biosciences Inc.
Follow-On Offering
Active Bookrunner
Read more
about ESSAPharmaInc-2021-02-17
$149.9 Million
Image
ESSA Pharma Inc.
Follow-On Offering
Active Bookrunner
Read more
about NurixInc-2021-03-04
$160.4 Million
Image
Nurix Inc.
Follow-On Offering
Active Bookrunner
Read more
about TCR2Therapeutics-2021-01-19
$140.0 Million
Image
TCR2 Therapeutics
Follow-On Offering
Active Bookrunner
Read more
about CytomXTherapeuticsInc-2021-01-20
$114.9 Million
Image
CytomX Therapeutics Inc.
Follow-On Offering
Active Bookrunner
Read more
about OncorusInc-2021-02-11
$57.0 Million
Image
Oncorus, Inc.
Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹â¶Ä¹
Page 23
Next page
›â¶Äº
Subscribe to Active Bookrunner